Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

Intravitreal Aflibercept Injection for Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Study
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2020
Differences in Metamorphopsia and OCT Changes After Retinal Detachment Repair: RCT Comparing Pneumatic Retinopexy to Vitrectomy at 1 Year (PIVOT Trial)
Rajeev H. Muni, MD, MSC, FRCS(C), FASRS
Annual Meeting Talks
2018
LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more